Cecilia Jones has sold AGIO and made no open-market buys since Jun 2023

Cecilia Jones is the Chief Financial Officer (CFO) at Agios Pharmaceuticals, Inc. (AGIO), a biopharmaceutical company focused on rare diseases, where she joined in September 2022, replacing Jonathan Biller.( She recently sold 2,932 shares of AGIO stock on December 30, 2025, for approximately $79,427, following the exercise of 6,000 performance share units, and now directly owns 37,394 shares.(

Jones brings over 20 years of financial experience in the biopharmaceutical industry.( Prior to Agios, she was CFO at LogicBio, managing financial strategy, financing, business development, accounting, and investor relations. Before that, she spent over 10 years at Biogen in escalating finance roles, including Vice President of R&D, worldwide medical and business development finance, Senior Director of corporate finance, and Director of finance for emerging markets. Earlier, she served as Director of international finance at Genzyme. She holds a Licenciatura en Economia from Universidad de San Andres in Buenos Aires, Argentina, and an MBA from Harvard Business School.(

Written by Perplexity from public sources.